MR. DAVID PAUL GOLDSTEIN, M.D.
Medical Practice at Zanker Rd, San Jose, CA
License number
California G12694
Category
Medical Practice
Type
Gynecology
Address
Address
2
3500 Zanker Rd, San Jose, CA 95134
1600 Ms 2-3 RM 205, Sacramento, CA 95814
1600 Ms 2-3 RM 205, Sacramento, CA 95814
Phone
(408) 451-6198
(916) 654-2431
(916) 654-3186 (Fax)
(916) 654-2431
(916) 654-3186 (Fax)
Professional information
Dr. David P Goldstein, San Jose CA - MD (Doctor of Medicine)
Specialties:
Psychiatry, Obstetrics & Gynecology
Address:
1625 The Alameda STE 306, San Jose 95126
(650) 961-8923 (Phone), (408) 975-0764 (Fax)
3500 Zanker Rd, San Jose 95134
(408) 451-6198 (Phone)
(650) 961-8923 (Phone), (408) 975-0764 (Fax)
3500 Zanker Rd, San Jose 95134
(408) 451-6198 (Phone)
Languages:
English
Education:
Medical School
Thomas Jefferson University
Graduated: 1963
Mount Zion M C University Ca
Naval Reg Med Center
Stanford University Hospital
Thomas Jefferson University
Graduated: 1963
Mount Zion M C University Ca
Naval Reg Med Center
Stanford University Hospital
P38 Map Kinase Inhibitors
US Patent:
6479507, Nov 12, 2002
Filed:
Apr 19, 2001
Appl. No.:
09/839712
Inventors:
Soan Cheng - San Diego CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
Assignee:
Syntex (U.S.A.) LLC - Palo Alto CA
International Classification:
C07D49148
US Classification:
514301, 546114, 546115
Abstract:
The present invention relates to compounds of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Aminopyrrole Compounds
US Patent:
6696471, Feb 24, 2004
Filed:
Aug 29, 2002
Appl. No.:
10/231792
Inventors:
David Michael Goldstein - San Jose CA
David Mark Rotstein - Sunnyvale CA
David Mark Rotstein - Sunnyvale CA
Assignee:
Syntex (U.S.A.) LLC - Palo Alto CA
International Classification:
A61K 3144
US Classification:
514343, 5462791
Abstract:
The present invention provides an aminopyrrole compound of the formula: a prodrug, individual isomer, a mixture of isomers or a pharmaceutically acceptable salt thereof, where R , R , Ar and Ar are those defined herein. The present invention also provides methods of using and preparing the aminopyrrole compounds of Formula I.
David Paul Goldstein, San Jose CA
Specialties:
OB-GYN
Address:
3500 Zanker Rd, San Jose, CA 95134
Methods Of Inhibiting Btk And Syk Protein Kinases
US Patent:
7501410, Mar 10, 2009
Filed:
Mar 20, 2007
Appl. No.:
11/725752
Inventors:
David Michael Goldstein - San Jose CA, US
Matthias Rueth - Penzberg, DE
Matthias Rueth - Penzberg, DE
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
A61K 31/5377, A61K 31/502
US Classification:
5142328, 5142345, 514248
Abstract:
Methods of inhibiting a tyrosine kinase wherein said tyrosine kinase is BTK or SYK comprising administering to a patient in need thereof a therapeutically effective amount of a compound according to formula I are disclosed. The compounds are useful for treating auto-immune and inflammatory diseases.
P38 Map Kinase Inhibitors
US Patent:
6316464, Nov 13, 2001
Filed:
Oct 16, 1998
Appl. No.:
9/174299
Inventors:
Soan Cheng - San Diego CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
David Michael Goldstein - San Jose CA
Teresa Alejandra Trejo Martin - Palo Alto CA
Eric Brian Sjogren - Mountain View CA
Assignee:
Syntex (U.S.A.) LLC - Palo Alto CA
International Classification:
A01N 4342
US Classification:
514300
Abstract:
The present invention relates to compounds of Formula (I) ##STR1##
that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Imidazo-Substituted Compounds As P38 Kinase Inhibitors
US Patent:
7081462, Jul 25, 2006
Filed:
May 4, 2005
Appl. No.:
11/122137
Inventors:
David Michael Goldstein - San Jose CA, US
Ronald Charles Hawley - Mountain View CA, US
Alfred Sui-Ting Lui - Redwood City CA, US
Eric Brian Sjogren - Mountain View CA, US
Ronald Charles Hawley - Mountain View CA, US
Alfred Sui-Ting Lui - Redwood City CA, US
Eric Brian Sjogren - Mountain View CA, US
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
C07D 487/14, A61K 31/519, A61P 19/02, A61P 25/28
US Classification:
514267, 544251
Abstract:
The present invention discloses compounds corresponding to formula I:.
6-Alkoxy-Pyrido-Pyrimidines
US Patent:
7320987, Jan 22, 2008
Filed:
Mar 21, 2007
Appl. No.:
11/726339
Inventors:
David Michael Goldstein - San Jose CA, US
Julie Anne Lim - San Mateo CA, US
Julie Anne Lim - San Mateo CA, US
Assignee:
Roche Palo Alto LLC - Palo Alto CA
International Classification:
A01N 43/42, A61K 31/44
US Classification:
514299, 544279, 546122
Abstract:
The present invention provides compounds of the Formula I:.
7-Oxo-Pyridopyrimidines (Ii)
US Patent:
2004019, Sep 30, 2004
Filed:
Apr 1, 2004
Appl. No.:
10/816554
Inventors:
Humberto Arzeno - Cupertino CA, US
Jian Chen - Santa Clara CA, US
James Dunn - Los Altos CA, US
David Goldstein - San Jose CA, US
Julie Lim - San Mateo CA, US
Jian Chen - Santa Clara CA, US
James Dunn - Los Altos CA, US
David Goldstein - San Jose CA, US
Julie Lim - San Mateo CA, US
Assignee:
Syntex (U.S.A.) LLC
International Classification:
A61K031/519, C07D487/02
US Classification:
514/264110, 544/280000
Abstract:
The present invention provides compounds of the formula:
a prodrug or a pharmaceutically acceptable salt thereof, wherein R, R, Rand Arare those defined herein, and methods for preparation and uses thereof.
Prediction Of Bone Marrow Toxicity
US Patent:
2009020, Aug 20, 2009
Filed:
Feb 12, 2009
Appl. No.:
12/378437
Inventors:
Hans Marcus Ludwig Bitter - San Francisco CA, US
David Michael Goldstein - San Jose CA, US
Kyle Louis Kolaja - San Mateo CA, US
Henry Lin - Cupertino CA, US
Andrew James Olaharski - Sunnyvale CA, US
Hirdesh Uppal - Los Altos CA, US
David Michael Goldstein - San Jose CA, US
Kyle Louis Kolaja - San Mateo CA, US
Henry Lin - Cupertino CA, US
Andrew James Olaharski - Sunnyvale CA, US
Hirdesh Uppal - Los Altos CA, US
International Classification:
C12Q 1/48
US Classification:
435 15
Abstract:
The likelihood that a compound will exhibit bone marrow toxicity in an in vivo assay predicted by the ability of the compound to inhibit at least eight kinases from a selected group.